These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 7019187)

  • 21. Urinary excretion of beta-2-microglobulin and albumin during antibiotic therapy in urinary tract infections.
    Schena FP; De Cesaris R; Tedesco A; La Raia E; Bonomo L
    Contrib Nephrol; 1981; 26():42-9. PubMed ID: 6169487
    [No Abstract]   [Full Text] [Related]  

  • 22. Update on drug therapy: IX. Gentamicin and tobramycin nephrotoxicity.
    Darr MS; Elenbaas JK
    J Am Med Womens Assoc (1972); 1981 Oct; 36(10):310-6. PubMed ID: 7346536
    [No Abstract]   [Full Text] [Related]  

  • 23. Double-blind comparison of the nephrotoxicity and auditory toxicity of gentamicin and tobramycin.
    Smith CR; Lipsky JJ; Laskin OL; Hellmann DB; Mellits ED; Longstreth J; Lietman PS
    N Engl J Med; 1980 May; 302(20):1106-9. PubMed ID: 6988713
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [The use of tobramycin in severe infections (author's transl)].
    Babinet P; Bricaire F; Tancrede C; Goulon M
    Sem Hop; 1978 Oct 18-25; 54(33-36):1049-54. PubMed ID: 220716
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical evaluation of aminoglycoside toxicity: tobramycin versus gentamicin, a preliminary report.
    Fee WE; Vierra V; Lathrop GR
    J Antimicrob Chemother; 1978 May; 4 Suppl A():31-6. PubMed ID: 659347
    [No Abstract]   [Full Text] [Related]  

  • 26. Urinary alanine aminopeptidase and beta 2-microglobulin as measurements of aminoglycoside-associated renal impairment.
    Trollfors B; Bergmark J; Hiesche K; Jagenburg R
    Infection; 1984; 12(1):20-2. PubMed ID: 6142864
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Gentamicin vs. tobramycin.
    Med Lett Drugs Ther; 1980 Oct; 22(20):85-6. PubMed ID: 7421726
    [No Abstract]   [Full Text] [Related]  

  • 28. Urinary biomarkers in assessing the nephrotoxic potential of gentamicin in solitary kidney patients after 7 days of therapy.
    Gluhovschi G; Gadalean F; Gluhovschi C; Velciov S; Petrica L; Bob F; Bozdog G; Kaycsa A
    Ren Fail; 2014 May; 36(4):534-40. PubMed ID: 24456153
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Once-daily dosed gentamicin is more nephrotoxic than once-daily dosed tobramycin in clinically infected patients.
    van Maarseveen E; van Buul-Gast MC; Abdoellakhan R; Gelinck L; Neef C; Touw D
    J Antimicrob Chemother; 2014 Sep; 69(9):2581-3. PubMed ID: 24872345
    [No Abstract]   [Full Text] [Related]  

  • 30. Experience with a once-daily dosing program of aminoglycosides in critically ill patients.
    Buijk SE; Mouton JW; Gyssens IC; Verbrugh HA; Bruining HA
    Intensive Care Med; 2002 Jul; 28(7):936-42. PubMed ID: 12122533
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Renoprotective role of nifedipine during gentamicin therapy: randomized controlled trial.
    Vlasic-Matas J; Rumboldt Z; Karelovic D
    Croat Med J; 2000 Dec; 41(4):417-22. PubMed ID: 11063766
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Urinary excretion of adenosine deaminase binding protein in neonates treated with tobramycin.
    Gordjani N; Burghard R; Müller D; Mathäi H; Mergehenn G; Leititis JU; Brandis M
    Pediatr Nephrol; 1995 Aug; 9(4):419-22. PubMed ID: 7577399
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparative cost effectiveness of gentamicin and tobramycin.
    Holloway JJ; Smith CR; Moore RD; Feroli ER; Lietman PS
    Ann Intern Med; 1984 Dec; 101(6):764-9. PubMed ID: 6437310
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The aminoglycosides. Streptomycin, kanamycin, gentamicin, tobramycin, amikacin, netilmicin, sisomicin.
    Edson RS; Keys TF
    Mayo Clin Proc; 1983 Feb; 58(2):99-102. PubMed ID: 6823164
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Efficacy and safety of cefamandole plus either gentamicin or tobramycin in therapy of severe gram-negative bacterial infections.
    Gentry LO
    J Infect Dis; 1978 May; 137 Suppl():S144-S149. PubMed ID: 349093
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison of tobramycin and gentamicin in the treatment of complicated urinary tract infections.
    Madsen PO; Kjaer TB; Mosegaard A
    J Infect Dis; 1976 Aug; 134 Suppl():S150-2. PubMed ID: 972274
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Comparative study of tobramycin and gentamicin].
    Klastersky J; Daneau D; Henri A
    Acta Clin Belg; 1972; 27(5):589-99. PubMed ID: 4205788
    [No Abstract]   [Full Text] [Related]  

  • 38. [Nephrotoxicity of aminoglycoside antibiotics].
    Giura R; Roccamo B; Donghi M; Landriscina M
    G Ital Chemioter; 1979; 26(1-2):297-300. PubMed ID: 554820
    [No Abstract]   [Full Text] [Related]  

  • 39. Single daily doses of tobramycin in therapy of urinary tract infections.
    Landes RR
    J Infect Dis; 1976 Aug; 134 Suppl():S142-5. PubMed ID: 972273
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Lactic dehydrogenase isoenzymes in urinary tract infections and aminoglycoside nephrotoxicity.
    Lechi A; Rizzotti P; Mengoli C; Arosio E; Pancera P
    Infection; 1983; 11(1):52-3. PubMed ID: 6840866
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.